Your email has been successfully added to our mailing list.

×
0.0249999999999999 0.03 0.13 0.03 0.085 -0.0149999999999999 0.04 0.06125
Stock impact report

Zosano's lead product candidate successful in late-stage migraine study; shares ahead 46% premarket [Seeking Alpha]

Zosano Pharma Corporation (ZSAN) 
Last zosano pharma corporation earnings: 11/9 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.zosanopharma.com
Company Research Source: Seeking Alpha
Thinly traded nano cap Zosano Pharma (NASDAQ: ZSAN ) is up   premarket on robust volume in response to its announcement of successful results from a Phase 3 clinical trial, ZOTRIP , assessing lead product candidate M207 for the treatment of migraine. The study met both co-primary endpoints of pain freedom and most bothersome symptom freedom at hour 2. M207 is a zolmitriptan-coated microneedle patch is that is designed to rapidly deliver zolmitriptan during a migraine attack. Zolmitriptan was marketed as a branded medicine by AstraZeneca before coming off patent several years ago. The company is working toward an NDA filing, but has not released a time line for the submission. Now read: Yet Another Indictment For An Insys Salesperson » Show less Read more
Impact Snapshot
Event Time:
ZSAN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ZSAN alerts
Opt-in for
ZSAN alerts

from News Quantified
Opt-in for
ZSAN alerts

from News Quantified